|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Money market funds and interest-bearing deposits in other banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Held to maturity, at amortized cost-fair value of $112 in 2022 | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Available for sale, at fair value | ||||||||||||||||||||
| Securities: | ||||||||||||||||||||
| Available for sale, at fair value | ||||||||||||||||||||
| Other investments, at cost | ||||||||||||||||||||
| Loans held for sale, at fair value | ||||||||||||||||||||
| Loans held for investment, net of deferred fees and costs | ||||||||||||||||||||
| Net loans held for investment | ||||||||||||||||||||
| Less: allowance for credit losses | ||||||||||||||||||||
| Net loans held for investment | ||||||||||||||||||||
| Bank premises and equipment, net | ||||||||||||||||||||
| OREO | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Common stock, $5 par value, 6,000,000 shares authorized, 3,554,652 (2026) and 3,525,884 (2025) shares issued and outstanding | ||||||||||||||||||||
| Common stock held by deferred compensation trust, at par, 34,640 (2026) and 31,176 (2025) shares | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Additional paid in capital attributed to deferred compensation trust | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders' Equity | ||||||||||||||||||||
Loading...